175 related articles for article (PubMed ID: 11525275)
21. Metastatic papillary thyroid carcinoma presenting as a primary renal neoplasm.
Graham LD; Roe SM
Am Surg; 1995 Aug; 61(8):732-4. PubMed ID: 7618817
[TBL] [Abstract][Full Text] [Related]
22. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid cancer with bilateral adrenal metastases.
Batawil N
Thyroid; 2013 Dec; 23(12):1651-4. PubMed ID: 23683128
[TBL] [Abstract][Full Text] [Related]
24. Parapharyngeal lymph node metastasis: an unusual presentation of papillary thyroid carcinoma.
Lombardi D; Nicolai P; Antonelli AR; Maroldi R; Farina D; Shaha AR
Head Neck; 2004 Feb; 26(2):190-6. PubMed ID: 14762889
[TBL] [Abstract][Full Text] [Related]
25. Synchronous colon cancer with pulmonary metastasis and follicular variant of papillary thyroid cancer metastasising to kidney.
Kadamkulam Syriac A; Mirza M; Malekunnel AR; Locante A; Desai P
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30093473
[TBL] [Abstract][Full Text] [Related]
26. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
[TBL] [Abstract][Full Text] [Related]
27. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
[TBL] [Abstract][Full Text] [Related]
28. Papillary thyroid cancer with chest metastases only detected using radioactive iodine.
Kuo SF; Chen ST; Kao PF; Chang YC; Chou SC; Lin JD
Chang Gung Med J; 2004 Sep; 27(9):663-72. PubMed ID: 15605906
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
[TBL] [Abstract][Full Text] [Related]
30. Renal metastasis from papillary thyroid microcarcinoma.
Liou MJ; Lin JD; Chung MH; Liau CT; Hsueh C
Acta Otolaryngol; 2005 Apr; 125(4):438-42. PubMed ID: 15823819
[TBL] [Abstract][Full Text] [Related]
31. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients.
Pacini F; Elisei R; Capezzone M; Miccoli P; Molinaro E; Basolo F; Agate L; Bottici V; Raffaelli M; Pinchera A
Thyroid; 2001 Sep; 11(9):877-81. PubMed ID: 11575858
[TBL] [Abstract][Full Text] [Related]
32. False-Positive Uptake of Radioiodine in Renal Hamartoma in a Patient With Differentiated Thyroid Cancer.
Shen G; Qi Z; Huang R; Liu B; Kuang A
Clin Nucl Med; 2017 Sep; 42(9):709-710. PubMed ID: 28650888
[TBL] [Abstract][Full Text] [Related]
33. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
34. The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.
Wapnir IL; Goris M; Yudd A; Dohan O; Adelman D; Nowels K; Carrasco N
Clin Cancer Res; 2004 Jul; 10(13):4294-302. PubMed ID: 15240514
[TBL] [Abstract][Full Text] [Related]
35. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
[TBL] [Abstract][Full Text] [Related]
37. Papillary thyroid cancer with an initial presentation of abdominal and flank pain.
Ruggiero FP; Frauenhoffer EE; Stack BC
Am J Otolaryngol; 2005; 26(2):142-5. PubMed ID: 15742271
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
[TBL] [Abstract][Full Text] [Related]
39. Frontal sinus mucocele mimicking a metastasis of papillary thyroid carcinoma.
Matheja P; Lerch H; Schmid KW; Kuwert T; Schober O
J Nucl Med; 1997 Jul; 38(7):1022-4. PubMed ID: 9225783
[TBL] [Abstract][Full Text] [Related]
40. Renal metastasis from thyroid carcinoma: a case report.
Varinot J; Ménégaux F; Bitker MO; Compérat E
Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):46-50. PubMed ID: 24902371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
